Design and topline results of TransCon PTH, a long-acting PTH, phase 2 trial in patients with hypoparathyroidism

by David B. Karpf, Sanchita Mourya, Aliya Khan, Lars Rejnmark
Published 2020-10-01

The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency

by Kennett Sprogøe, Eva Mortensen, David B Karpf, Jonathan A Leff
Published 2017-10-01